CD20 tails interact with the 14-3-3/GEF-H1 complex and microtubule network upon PKCδ phosphorylation

Kathrin Kläsener1,2,3, Cindy Eunhee Lee4,5, Julian Bender6

  • 1Biology III, Faculty of Biology, University of Freiburg, Freiburg, Germany. kathrin.klaesener@bioss.uni-freiburg.de.

The EMBO Journal
|April 17, 2026
PubMed

Insights

CD20 protein anchors the B-cell antigen receptor nanocluster, maintaining resting B-lymphocytes. Anti-CD20 antibodies disrupt this, altering B-cell signaling and potentially impacting therapeutic outcomes.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • CD20 is a B-cell specific transmembrane protein and a key target for therapeutic antibodies.
  • CD20 localizes to IgD-BCR nanoclusters, regulating naïve B-lymphocyte resting state.
  • The precise mechanism of CD20's gatekeeper function in B-cells remains unclear.

Purpose of the Study:

  • To elucidate the molecular mechanism by which CD20 maintains the resting state of B-lymphocytes.
  • To investigate the role of CD20 phosphorylation and its interaction with downstream signaling molecules.
  • To understand how anti-CD20 antibodies affect CD20 localization and B-cell function.

Main Methods:

  • Utilized Ramos cells and human peripheral blood B-cells.
  • Investigated constitutive phosphorylation of CD20 by PKCδ.
  • Examined binding interactions between CD20, 14-3-3 proteins, GEF-H1, and the microtubule network.
  • Analyzed changes in protein complexes upon anti-CD20 antibody binding, including RhoA-GTP/ROCK1.

Main Results:

  • PKCδ constitutively phosphorylates CD20 on serine residues in its cytosolic tails.
  • Phosphorylated CD20 binds 14-3-3 proteins, linking to GEF-H1 and the microtubule network, stabilizing the IgD-BCR nanocluster.
  • Anti-CD20 antibodies induce microtubule dissociation and formation of a RhoA-GTP/ROCK1/CD20 complex, promoting actomyosin contractility.
  • CD20 anchors microtubules to maintain B-cell quiescence and mediates a microtubule-actin switch upon activation.

Conclusions:

  • CD20 acts as a gatekeeper for resting B-lymphocytes by anchoring the microtubule network and stabilizing IgD-BCR nanoclusters.
  • CD20 orchestrates a signaling switch from microtubule-based to actin-based regulation during B-cell activation.
  • These findings offer insights into CD20 function and may inform anti-CD20 antibody therapy optimization.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.2K
Tail-anchoring of Proteins in the ER Membrane01:45

Tail-anchoring of Proteins in the ER Membrane

Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
4.1K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
7.2K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.4K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
7.2K